Home / Companies / Akero Therapeutics, Inc. / 7 Jun 2024
Akero Therapeutics, Inc.: meeting of 7 Jun 2024
Votes reported on Form N-PX, item by item
304 Form N-PX filers reported votes at the Akero Therapeutics, Inc. meeting of 7 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 22.7% of reported votes for; 116 filers withheld from or voted against at least one nominee.
647 vote records from 122 filers. 106 of the 121 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
454 vote records from 303 filers. 38 of the 290 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
217 vote records from 122 filers. 2 of the 121 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
216 vote records from 121 filers. 12 of the 120 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | Abstain or withhold * | For | For |
| Fidelity | Abstain or withhold * | For | For |
| Dimensional | Abstain or withhold * | For | For |
| State Street and SPDR | Abstain or withhold * | For | For |
| American Century | Abstain or withhold * | Against * | For |
| Franklin Templeton | No report | For | No report |
| Invesco | Abstain or withhold * | Against * | For |
| Equitable | Abstain or withhold * | For | For |
| Charles Schwab | Abstain or withhold * | For | For |
| Nuveen and TIAA | Abstain or withhold * | For | For |
| ProShares and ProFunds | Abstain or withhold * | For | For |
| John Hancock and Manulife | Abstain or withhold * | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Abstain or withhold * | For | For |
| PGIM and Prudential | Abstain or withhold * | For | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | Abstain or withhold * | For | For |
| T. Rowe Price | Abstain or withhold * | For | For |
| Lincoln Financial | Abstain or withhold | For | For |
| Voya | Abstain or withhold * | For | For |
| Nationwide | Abstain or withhold * | For | For |
| Victory Capital | Abstain or withhold * | For | For |
| Brighthouse Funds | Abstain or withhold * | For | For |
| Guggenheim and Rydex | Abstain or withhold * | For | For |
| Columbia Threadneedle | No report | For | No report |
| BNY Mellon | No report | For | No report |
| Principal | Abstain or withhold * | For | For |
| Pacific Life funds | Abstain or withhold * | For | For |
| Global X | Abstain or withhold * | For | For |
| Transamerica | Abstain or withhold * | For | For |
| AllianceBernstein | Abstain or withhold * | For | For |
| Hartford Funds | Abstain or withhold * | For | For |
| DWS | Abstain or withhold * | For | For |
| MassMutual | Abstain or withhold * | For | For |
| Janus Henderson | Abstain or withhold * | For | For |
| Neuberger Berman | No report | For | No report |
| Natixis and Loomis Sayles | No report | For | No report |
| Artisan Partners | For | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Akero Therapeutics, Inc. meeting?
304 Form N-PX filers reported votes at the meeting of 7 Jun 2024. On say-on-pay, 38 of 290 voted against management (13.1%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Akero Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Akero Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Akero Therapeutics, Inc. with a meeting date within three days of 7 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.